retrospective analysis of 886 patients found retained gastric contents in 24.2% of semaglutide patients versus 5.1% of controls (adjusted odds ratio 5.15, 95% confidence interval 1.9212.92), yet actual aspiration occurred in only 1 of 404 patients (0.24%) [31]
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
Guldemir HH, Buyukuslu N, Yigit P, Cakici C, Ozdemir EM
Currently, more than 1 million legitimate prescriptions for Ozempic, Wegovy, and other GLP-1 medications are filled each week in the US.[1] Its worth noting that while Ozempic is the GLP-1 drug most linked in the public eye to weight loss, the medication is still only approved by the FDA as a treatment for diabetes
Prendre du glutathion en complment aide rtablir ces niveaux et renforcer la capacit du corps combattre les infections